Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis
Aditi Gupta(University of Maryland, Baltimore), Meenakshi A. Chellaiah(University of Maryland, Baltimore)
Cited by 76
Related Papers
Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells
|Molecular Cancer|2010|65
C-phycocyanin attenuates RANKL-induced osteoclastogenesis and bone resorption in vitro through inhibiting ROS levels, NFATc1 and NF-κB activation
|Scientific Reports|2020|46
Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells
|Cell Communication and Signaling|2019|44
Promising Noninvasive Cellular Phenotype in Prostate Cancer Cells Knockdown of Matrix Metalloproteinase 9
|The Scientific World JOURNAL|2013|34
Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2
|Journal of Cellular Biochemistry|2018|31